nodes	percent_of_prediction	percent_of_DWPC	metapath
Ketoconazole—P-Glycoprotein Inhibitors—Cyclosporine—psoriasis	0.251	0.521	CiPCiCtD
Ketoconazole—Cytochrome P450 3A4 Inhibitors—Cyclosporine—psoriasis	0.231	0.479	CiPCiCtD
Ketoconazole—CYP26A1—Acitretin—psoriasis	0.0852	0.217	CbGbCtD
Ketoconazole—CYP24A1—Calcipotriol—psoriasis	0.076	0.194	CbGbCtD
Ketoconazole—CYP24A1—Calcitriol—psoriasis	0.0513	0.131	CbGbCtD
Ketoconazole—CYP11B2—Hydrocortisone—psoriasis	0.0163	0.0415	CbGbCtD
Ketoconazole—CYP11A1—Cholecalciferol—psoriasis	0.0127	0.0324	CbGbCtD
Ketoconazole—CYP11B1—Hydrocortisone—psoriasis	0.0106	0.0269	CbGbCtD
Ketoconazole—CYP1A1—Clobetasol propionate—psoriasis	0.0092	0.0235	CbGbCtD
Ketoconazole—CYP17A1—Dexamethasone—psoriasis	0.00657	0.0168	CbGbCtD
Ketoconazole—CYP2A6—Methoxsalen—psoriasis	0.00565	0.0144	CbGbCtD
Ketoconazole—CYP11A1—Dexamethasone—psoriasis	0.00549	0.014	CbGbCtD
Ketoconazole—CYP1A1—Methoxsalen—psoriasis	0.00483	0.0123	CbGbCtD
Ketoconazole—ABCB11—Cyclosporine—psoriasis	0.00479	0.0122	CbGbCtD
Ketoconazole—CYP19A1—Betamethasone—psoriasis	0.0044	0.0112	CbGbCtD
Ketoconazole—CYP2C8—Tazarotene—psoriasis	0.00433	0.011	CbGbCtD
Ketoconazole—CYP3A5—Beclomethasone—psoriasis	0.00418	0.0107	CbGbCtD
Ketoconazole—CYP1A2—Clobetasol propionate—psoriasis	0.00411	0.0105	CbGbCtD
Ketoconazole—SLCO1A2—Prednisolone—psoriasis	0.0034	0.00866	CbGbCtD
Ketoconazole—SLCO1A2—Hydrocortisone—psoriasis	0.00322	0.00821	CbGbCtD
Ketoconazole—SLCO1A2—Prednisone—psoriasis	0.00321	0.00818	CbGbCtD
Ketoconazole—CYP1A1—Cholecalciferol—psoriasis	0.0032	0.00816	CbGbCtD
Ketoconazole—ABCB11—Dexamethasone—psoriasis	0.00316	0.00805	CbGbCtD
Ketoconazole—CYP1B1—Dexamethasone—psoriasis	0.00316	0.00805	CbGbCtD
Ketoconazole—SLCO1A2—Cyclosporine—psoriasis	0.00304	0.00776	CbGbCtD
Ketoconazole—CYP2A6—Prednisolone—psoriasis	0.00275	0.00701	CbGbCtD
Ketoconazole—CYP19A1—Dexamethasone—psoriasis	0.00256	0.00653	CbGbCtD
Ketoconazole—CYP2B6—Cholecalciferol—psoriasis	0.00244	0.00622	CbGbCtD
Ketoconazole—CYP1A2—Methoxsalen—psoriasis	0.00216	0.00551	CbGbCtD
Ketoconazole—SLCO1A2—Dexamethasone—psoriasis	0.002	0.00511	CbGbCtD
Ketoconazole—CYP2D6—Hydroxyurea—psoriasis	0.00194	0.00496	CbGbCtD
Ketoconazole—CYP2C8—Cholecalciferol—psoriasis	0.00185	0.00471	CbGbCtD
Ketoconazole—CYP3A7—Hydrocortisone—psoriasis	0.00178	0.00455	CbGbCtD
Ketoconazole—CYP3A7-CYP3A51P—Hydrocortisone—psoriasis	0.00178	0.00455	CbGbCtD
Ketoconazole—CYP3A7-CYP3A51P—Cyclosporine—psoriasis	0.00168	0.00429	CbGbCtD
Ketoconazole—CYP3A7—Cyclosporine—psoriasis	0.00168	0.00429	CbGbCtD
Ketoconazole—CYP3A5—Mycophenolate mofetil—psoriasis	0.00167	0.00425	CbGbCtD
Ketoconazole—CYP2A6—Dexamethasone—psoriasis	0.00162	0.00414	CbGbCtD
Ketoconazole—SLCO1A2—Methotrexate—psoriasis	0.00161	0.0041	CbGbCtD
Ketoconazole—CYP2C8—Mycophenolate mofetil—psoriasis	0.0016	0.00409	CbGbCtD
Ketoconazole—CYP2C19—Cholecalciferol—psoriasis	0.00155	0.00395	CbGbCtD
Ketoconazole—CYP3A4—Calcitriol—psoriasis	0.00145	0.00371	CbGbCtD
Ketoconazole—CYP1A1—Dexamethasone—psoriasis	0.00138	0.00353	CbGbCtD
Ketoconazole—CYP3A5—Hydrocortisone—psoriasis	0.00134	0.00341	CbGbCtD
Ketoconazole—CYP2C9—Cholecalciferol—psoriasis	0.00129	0.00329	CbGbCtD
Ketoconazole—CYP2C8—Hydrocortisone—psoriasis	0.00129	0.00328	CbGbCtD
Ketoconazole—CYP3A5—Cyclosporine—psoriasis	0.00126	0.00322	CbGbCtD
Ketoconazole—CYP2C8—Cyclosporine—psoriasis	0.00121	0.0031	CbGbCtD
Ketoconazole—CYP2D6—Cholecalciferol—psoriasis	0.00118	0.00301	CbGbCtD
Ketoconazole—CYP3A4—Methoxsalen—psoriasis	0.00113	0.00288	CbGbCtD
Ketoconazole—CYP3A7—Dexamethasone—psoriasis	0.00111	0.00283	CbGbCtD
Ketoconazole—CYP3A7-CYP3A51P—Dexamethasone—psoriasis	0.00111	0.00283	CbGbCtD
Ketoconazole—ABCB1—Mycophenolate mofetil—psoriasis	0.00108	0.00277	CbGbCtD
Ketoconazole—CYP2C19—Prednisone—psoriasis	0.00107	0.00274	CbGbCtD
Ketoconazole—CYP2B6—Dexamethasone—psoriasis	0.00106	0.00269	CbGbCtD
Ketoconazole—CYP2C19—Cyclosporine—psoriasis	0.00102	0.0026	CbGbCtD
Ketoconazole—ABCB1—Betamethasone—psoriasis	0.00093	0.00237	CbGbCtD
Ketoconazole—ABCB1—Prednisolone—psoriasis	0.000918	0.00234	CbGbCtD
Ketoconazole—ABCB1—Hydrocortisone—psoriasis	0.00087	0.00222	CbGbCtD
Ketoconazole—ABCB1—Prednisone—psoriasis	0.000867	0.00221	CbGbCtD
Ketoconazole—CYP2C9—Cyclosporine—psoriasis	0.000846	0.00216	CbGbCtD
Ketoconazole—CYP3A5—Dexamethasone—psoriasis	0.000831	0.00212	CbGbCtD
Ketoconazole—ABCB1—Cyclosporine—psoriasis	0.000821	0.0021	CbGbCtD
Ketoconazole—CYP2C8—Dexamethasone—psoriasis	0.000799	0.00204	CbGbCtD
Ketoconazole—CYP2D6—Cyclosporine—psoriasis	0.000774	0.00197	CbGbCtD
Ketoconazole—CYP3A4—Cholecalciferol—psoriasis	0.000749	0.00191	CbGbCtD
Ketoconazole—CYP2C19—Dexamethasone—psoriasis	0.00067	0.00171	CbGbCtD
Ketoconazole—CYP3A4—Triamcinolone—psoriasis	0.000649	0.00166	CbGbCtD
Ketoconazole—CYP3A4—Mycophenolate mofetil—psoriasis	0.000649	0.00166	CbGbCtD
Ketoconazole—CYP2C9—Dexamethasone—psoriasis	0.000557	0.00142	CbGbCtD
Ketoconazole—CYP3A4—Betamethasone—psoriasis	0.000557	0.00142	CbGbCtD
Ketoconazole—CYP3A4—Prednisolone—psoriasis	0.00055	0.0014	CbGbCtD
Ketoconazole—ABCB1—Dexamethasone—psoriasis	0.000541	0.00138	CbGbCtD
Ketoconazole—CYP3A4—Hydrocortisone—psoriasis	0.000521	0.00133	CbGbCtD
Ketoconazole—CYP3A4—Prednisone—psoriasis	0.000519	0.00132	CbGbCtD
Ketoconazole—CYP2D6—Dexamethasone—psoriasis	0.00051	0.0013	CbGbCtD
Ketoconazole—CYP3A4—Cyclosporine—psoriasis	0.000492	0.00126	CbGbCtD
Ketoconazole—ABCB1—Methotrexate—psoriasis	0.000435	0.00111	CbGbCtD
Ketoconazole—CYP3A4—Dexamethasone—psoriasis	0.000324	0.000827	CbGbCtD
Ketoconazole—Fatigue—Cyclosporine—psoriasis	3.07e-05	0.000364	CcSEcCtD
Ketoconazole—Dyspepsia—Mycophenolate mofetil—psoriasis	3.06e-05	0.000362	CcSEcCtD
Ketoconazole—Pain—Cyclosporine—psoriasis	3.05e-05	0.000361	CcSEcCtD
Ketoconazole—Constipation—Cyclosporine—psoriasis	3.05e-05	0.000361	CcSEcCtD
Ketoconazole—Dry mouth—Triamcinolone—psoriasis	3.04e-05	0.00036	CcSEcCtD
Ketoconazole—Angioedema—Dexamethasone—psoriasis	3.03e-05	0.000359	CcSEcCtD
Ketoconazole—Angioedema—Betamethasone—psoriasis	3.03e-05	0.000359	CcSEcCtD
Ketoconazole—Decreased appetite—Mycophenolate mofetil—psoriasis	3.02e-05	0.000358	CcSEcCtD
Ketoconazole—Anorexia—Hydrocortisone—psoriasis	3.02e-05	0.000357	CcSEcCtD
Ketoconazole—Diarrhoea—Mycophenolic acid—psoriasis	3.01e-05	0.000357	CcSEcCtD
Ketoconazole—Angiopathy—Prednisone—psoriasis	3.01e-05	0.000356	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	3e-05	0.000355	CcSEcCtD
Ketoconazole—Immune system disorder—Prednisone—psoriasis	3e-05	0.000355	CcSEcCtD
Ketoconazole—Malaise—Dexamethasone—psoriasis	2.99e-05	0.000354	CcSEcCtD
Ketoconazole—Malaise—Betamethasone—psoriasis	2.99e-05	0.000354	CcSEcCtD
Ketoconazole—Anaphylactic shock—Triamcinolone—psoriasis	2.98e-05	0.000353	CcSEcCtD
Ketoconazole—Pain—Mycophenolate mofetil—psoriasis	2.97e-05	0.000352	CcSEcCtD
Ketoconazole—Constipation—Mycophenolate mofetil—psoriasis	2.97e-05	0.000352	CcSEcCtD
Ketoconazole—Arrhythmia—Prednisone—psoriasis	2.96e-05	0.000351	CcSEcCtD
Ketoconazole—Feeling abnormal—Cyclosporine—psoriasis	2.94e-05	0.000348	CcSEcCtD
Ketoconazole—Insomnia—Prednisolone—psoriasis	2.93e-05	0.000347	CcSEcCtD
Ketoconazole—Alopecia—Prednisone—psoriasis	2.93e-05	0.000347	CcSEcCtD
Ketoconazole—Hepatobiliary disease—Methotrexate—psoriasis	2.92e-05	0.000346	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Cyclosporine—psoriasis	2.91e-05	0.000345	CcSEcCtD
Ketoconazole—Dizziness—Mycophenolic acid—psoriasis	2.91e-05	0.000345	CcSEcCtD
Ketoconazole—Epistaxis—Methotrexate—psoriasis	2.91e-05	0.000345	CcSEcCtD
Ketoconazole—Paraesthesia—Prednisolone—psoriasis	2.91e-05	0.000345	CcSEcCtD
Ketoconazole—Mental disorder—Prednisone—psoriasis	2.91e-05	0.000344	CcSEcCtD
Ketoconazole—Erythema—Prednisone—psoriasis	2.89e-05	0.000342	CcSEcCtD
Ketoconazole—Malnutrition—Prednisone—psoriasis	2.89e-05	0.000342	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Hydrocortisone—psoriasis	2.89e-05	0.000341	CcSEcCtD
Ketoconazole—Feeling abnormal—Mycophenolate mofetil—psoriasis	2.86e-05	0.000339	CcSEcCtD
Ketoconazole—Insomnia—Hydrocortisone—psoriasis	2.86e-05	0.000339	CcSEcCtD
Ketoconazole—Paraesthesia—Hydrocortisone—psoriasis	2.84e-05	0.000337	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	2.84e-05	0.000336	CcSEcCtD
Ketoconazole—Urticaria—Cyclosporine—psoriasis	2.83e-05	0.000335	CcSEcCtD
Ketoconazole—Myalgia—Betamethasone—psoriasis	2.82e-05	0.000334	CcSEcCtD
Ketoconazole—Myalgia—Dexamethasone—psoriasis	2.82e-05	0.000334	CcSEcCtD
Ketoconazole—Body temperature increased—Cyclosporine—psoriasis	2.82e-05	0.000333	CcSEcCtD
Ketoconazole—Abdominal pain—Cyclosporine—psoriasis	2.82e-05	0.000333	CcSEcCtD
Ketoconazole—Vomiting—Mycophenolic acid—psoriasis	2.8e-05	0.000331	CcSEcCtD
Ketoconazole—Discomfort—Dexamethasone—psoriasis	2.79e-05	0.00033	CcSEcCtD
Ketoconazole—Discomfort—Betamethasone—psoriasis	2.79e-05	0.00033	CcSEcCtD
Ketoconazole—Dyspepsia—Hydrocortisone—psoriasis	2.79e-05	0.00033	CcSEcCtD
Ketoconazole—Rash—Mycophenolic acid—psoriasis	2.78e-05	0.000329	CcSEcCtD
Ketoconazole—Dermatitis—Mycophenolic acid—psoriasis	2.77e-05	0.000328	CcSEcCtD
Ketoconazole—Pain—Prednisolone—psoriasis	2.77e-05	0.000328	CcSEcCtD
Ketoconazole—Hepatitis—Methotrexate—psoriasis	2.77e-05	0.000328	CcSEcCtD
Ketoconazole—Urticaria—Mycophenolate mofetil—psoriasis	2.76e-05	0.000327	CcSEcCtD
Ketoconazole—Headache—Mycophenolic acid—psoriasis	2.76e-05	0.000327	CcSEcCtD
Ketoconazole—Decreased appetite—Hydrocortisone—psoriasis	2.75e-05	0.000326	CcSEcCtD
Ketoconazole—Abdominal pain—Mycophenolate mofetil—psoriasis	2.75e-05	0.000325	CcSEcCtD
Ketoconazole—Body temperature increased—Mycophenolate mofetil—psoriasis	2.75e-05	0.000325	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Hydrocortisone—psoriasis	2.73e-05	0.000324	CcSEcCtD
Ketoconazole—Fatigue—Hydrocortisone—psoriasis	2.73e-05	0.000323	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Triamcinolone—psoriasis	2.72e-05	0.000322	CcSEcCtD
Ketoconazole—Pain—Hydrocortisone—psoriasis	2.71e-05	0.000321	CcSEcCtD
Ketoconazole—Anaphylactic shock—Betamethasone—psoriasis	2.71e-05	0.00032	CcSEcCtD
Ketoconazole—Anaphylactic shock—Dexamethasone—psoriasis	2.71e-05	0.00032	CcSEcCtD
Ketoconazole—Insomnia—Triamcinolone—psoriasis	2.7e-05	0.000319	CcSEcCtD
Ketoconazole—Ill-defined disorder—Prednisone—psoriasis	2.68e-05	0.000317	CcSEcCtD
Ketoconazole—Paraesthesia—Triamcinolone—psoriasis	2.68e-05	0.000317	CcSEcCtD
Ketoconazole—Feeling abnormal—Prednisolone—psoriasis	2.67e-05	0.000316	CcSEcCtD
Ketoconazole—Nervous system disorder—Dexamethasone—psoriasis	2.65e-05	0.000314	CcSEcCtD
Ketoconazole—Nervous system disorder—Betamethasone—psoriasis	2.65e-05	0.000314	CcSEcCtD
Ketoconazole—Thrombocytopenia—Betamethasone—psoriasis	2.65e-05	0.000314	CcSEcCtD
Ketoconazole—Thrombocytopenia—Dexamethasone—psoriasis	2.65e-05	0.000314	CcSEcCtD
Ketoconazole—Angioedema—Prednisone—psoriasis	2.64e-05	0.000312	CcSEcCtD
Ketoconazole—Hypersensitivity—Cyclosporine—psoriasis	2.63e-05	0.000311	CcSEcCtD
Ketoconazole—Dyspepsia—Triamcinolone—psoriasis	2.62e-05	0.000311	CcSEcCtD
Ketoconazole—Erythema multiforme—Methotrexate—psoriasis	2.62e-05	0.00031	CcSEcCtD
Ketoconazole—Nausea—Mycophenolic acid—psoriasis	2.62e-05	0.00031	CcSEcCtD
Ketoconazole—Feeling abnormal—Hydrocortisone—psoriasis	2.61e-05	0.000309	CcSEcCtD
Ketoconazole—Malaise—Prednisone—psoriasis	2.6e-05	0.000308	CcSEcCtD
Ketoconazole—Eye disorder—Methotrexate—psoriasis	2.59e-05	0.000307	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Hydrocortisone—psoriasis	2.59e-05	0.000307	CcSEcCtD
Ketoconazole—Anorexia—Betamethasone—psoriasis	2.58e-05	0.000305	CcSEcCtD
Ketoconazole—Anorexia—Dexamethasone—psoriasis	2.58e-05	0.000305	CcSEcCtD
Ketoconazole—Urticaria—Prednisolone—psoriasis	2.58e-05	0.000305	CcSEcCtD
Ketoconazole—Fatigue—Triamcinolone—psoriasis	2.57e-05	0.000304	CcSEcCtD
Ketoconazole—Hypersensitivity—Mycophenolate mofetil—psoriasis	2.56e-05	0.000303	CcSEcCtD
Ketoconazole—Asthenia—Cyclosporine—psoriasis	2.56e-05	0.000303	CcSEcCtD
Ketoconazole—Pain—Triamcinolone—psoriasis	2.55e-05	0.000302	CcSEcCtD
Ketoconazole—Pruritus—Cyclosporine—psoriasis	2.52e-05	0.000298	CcSEcCtD
Ketoconazole—Urticaria—Hydrocortisone—psoriasis	2.52e-05	0.000298	CcSEcCtD
Ketoconazole—Angiopathy—Methotrexate—psoriasis	2.51e-05	0.000298	CcSEcCtD
Ketoconazole—Immune system disorder—Methotrexate—psoriasis	2.5e-05	0.000296	CcSEcCtD
Ketoconazole—Abdominal pain—Hydrocortisone—psoriasis	2.5e-05	0.000296	CcSEcCtD
Ketoconazole—Body temperature increased—Hydrocortisone—psoriasis	2.5e-05	0.000296	CcSEcCtD
Ketoconazole—Mediastinal disorder—Methotrexate—psoriasis	2.5e-05	0.000296	CcSEcCtD
Ketoconazole—Asthenia—Mycophenolate mofetil—psoriasis	2.49e-05	0.000295	CcSEcCtD
Ketoconazole—Chills—Methotrexate—psoriasis	2.49e-05	0.000294	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Dexamethasone—psoriasis	2.46e-05	0.000292	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Betamethasone—psoriasis	2.46e-05	0.000292	CcSEcCtD
Ketoconazole—Pruritus—Mycophenolate mofetil—psoriasis	2.46e-05	0.000291	CcSEcCtD
Ketoconazole—Myalgia—Prednisone—psoriasis	2.46e-05	0.000291	CcSEcCtD
Ketoconazole—Arthralgia—Prednisone—psoriasis	2.46e-05	0.000291	CcSEcCtD
Ketoconazole—Feeling abnormal—Triamcinolone—psoriasis	2.46e-05	0.000291	CcSEcCtD
Ketoconazole—Alopecia—Methotrexate—psoriasis	2.45e-05	0.00029	CcSEcCtD
Ketoconazole—Insomnia—Dexamethasone—psoriasis	2.45e-05	0.00029	CcSEcCtD
Ketoconazole—Insomnia—Betamethasone—psoriasis	2.45e-05	0.00029	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	2.44e-05	0.000289	CcSEcCtD
Ketoconazole—Diarrhoea—Cyclosporine—psoriasis	2.44e-05	0.000289	CcSEcCtD
Ketoconazole—CYP2A6—Fluoropyrimidine Activity—TP53—psoriasis	2.43e-05	0.000589	CbGpPWpGaD
Ketoconazole—Paraesthesia—Betamethasone—psoriasis	2.43e-05	0.000288	CcSEcCtD
Ketoconazole—Paraesthesia—Dexamethasone—psoriasis	2.43e-05	0.000288	CcSEcCtD
Ketoconazole—Discomfort—Prednisone—psoriasis	2.43e-05	0.000287	CcSEcCtD
Ketoconazole—Mental disorder—Methotrexate—psoriasis	2.43e-05	0.000287	CcSEcCtD
Ketoconazole—CYP11A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.42e-05	0.000588	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism—CYP2S1—psoriasis	2.42e-05	0.000586	CbGpPWpGaD
Ketoconazole—Malnutrition—Methotrexate—psoriasis	2.41e-05	0.000286	CcSEcCtD
Ketoconazole—Erythema—Methotrexate—psoriasis	2.41e-05	0.000286	CcSEcCtD
Ketoconazole—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	2.41e-05	0.000584	CbGpPWpGaD
Ketoconazole—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	2.4e-05	0.000581	CbGpPWpGaD
Ketoconazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CARM1—psoriasis	2.39e-05	0.00058	CbGpPWpGaD
Ketoconazole—Hypersensitivity—Prednisolone—psoriasis	2.39e-05	0.000283	CcSEcCtD
Ketoconazole—Dyspepsia—Dexamethasone—psoriasis	2.38e-05	0.000282	CcSEcCtD
Ketoconazole—Dyspepsia—Betamethasone—psoriasis	2.38e-05	0.000282	CcSEcCtD
Ketoconazole—Diarrhoea—Mycophenolate mofetil—psoriasis	2.38e-05	0.000282	CcSEcCtD
Ketoconazole—AR—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	2.37e-05	0.000575	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	2.37e-05	0.000574	CbGpPWpGaD
Ketoconazole—Urticaria—Triamcinolone—psoriasis	2.37e-05	0.00028	CcSEcCtD
Ketoconazole—Dysgeusia—Methotrexate—psoriasis	2.36e-05	0.00028	CcSEcCtD
Ketoconazole—Body temperature increased—Triamcinolone—psoriasis	2.36e-05	0.000279	CcSEcCtD
Ketoconazole—Dizziness—Cyclosporine—psoriasis	2.36e-05	0.000279	CcSEcCtD
Ketoconazole—Anaphylactic shock—Prednisone—psoriasis	2.36e-05	0.000279	CcSEcCtD
Ketoconazole—Decreased appetite—Betamethasone—psoriasis	2.35e-05	0.000278	CcSEcCtD
Ketoconazole—Decreased appetite—Dexamethasone—psoriasis	2.35e-05	0.000278	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Betamethasone—psoriasis	2.34e-05	0.000276	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Dexamethasone—psoriasis	2.34e-05	0.000276	CcSEcCtD
Ketoconazole—Hypersensitivity—Hydrocortisone—psoriasis	2.33e-05	0.000276	CcSEcCtD
Ketoconazole—Fatigue—Dexamethasone—psoriasis	2.33e-05	0.000276	CcSEcCtD
Ketoconazole—Fatigue—Betamethasone—psoriasis	2.33e-05	0.000276	CcSEcCtD
Ketoconazole—Pain—Dexamethasone—psoriasis	2.31e-05	0.000274	CcSEcCtD
Ketoconazole—Pain—Betamethasone—psoriasis	2.31e-05	0.000274	CcSEcCtD
Ketoconazole—Nervous system disorder—Prednisone—psoriasis	2.31e-05	0.000273	CcSEcCtD
Ketoconazole—Dizziness—Mycophenolate mofetil—psoriasis	2.3e-05	0.000272	CcSEcCtD
Ketoconazole—Skin disorder—Prednisone—psoriasis	2.29e-05	0.000271	CcSEcCtD
Ketoconazole—CYP26A1—Metabolism—CARM1—psoriasis	2.28e-05	0.000554	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism—NDUFA5—psoriasis	2.28e-05	0.000554	CbGpPWpGaD
Ketoconazole—Asthenia—Hydrocortisone—psoriasis	2.27e-05	0.000269	CcSEcCtD
Ketoconazole—Vomiting—Cyclosporine—psoriasis	2.27e-05	0.000268	CcSEcCtD
Ketoconazole—Rash—Cyclosporine—psoriasis	2.25e-05	0.000266	CcSEcCtD
Ketoconazole—Anorexia—Prednisone—psoriasis	2.25e-05	0.000266	CcSEcCtD
Ketoconazole—Dermatitis—Cyclosporine—psoriasis	2.24e-05	0.000266	CcSEcCtD
Ketoconazole—Pruritus—Hydrocortisone—psoriasis	2.24e-05	0.000265	CcSEcCtD
Ketoconazole—Ill-defined disorder—Methotrexate—psoriasis	2.24e-05	0.000265	CcSEcCtD
Ketoconazole—Headache—Cyclosporine—psoriasis	2.23e-05	0.000264	CcSEcCtD
Ketoconazole—Feeling abnormal—Betamethasone—psoriasis	2.23e-05	0.000264	CcSEcCtD
Ketoconazole—Feeling abnormal—Dexamethasone—psoriasis	2.23e-05	0.000264	CcSEcCtD
Ketoconazole—AR—Generic Transcription Pathway—CARM1—psoriasis	2.22e-05	0.000538	CbGpPWpGaD
Ketoconazole—Gastrointestinal pain—Betamethasone—psoriasis	2.21e-05	0.000262	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Dexamethasone—psoriasis	2.21e-05	0.000262	CcSEcCtD
Ketoconazole—CYP11A1—Metabolism—CYP2S1—psoriasis	2.21e-05	0.000536	CbGpPWpGaD
Ketoconazole—Vomiting—Mycophenolate mofetil—psoriasis	2.21e-05	0.000262	CcSEcCtD
Ketoconazole—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	2.2e-05	0.000534	CbGpPWpGaD
Ketoconazole—Hypersensitivity—Triamcinolone—psoriasis	2.2e-05	0.00026	CcSEcCtD
Ketoconazole—Rash—Mycophenolate mofetil—psoriasis	2.19e-05	0.000259	CcSEcCtD
Ketoconazole—Dermatitis—Mycophenolate mofetil—psoriasis	2.19e-05	0.000259	CcSEcCtD
Ketoconazole—Headache—Mycophenolate mofetil—psoriasis	2.18e-05	0.000258	CcSEcCtD
Ketoconazole—Malaise—Methotrexate—psoriasis	2.18e-05	0.000258	CcSEcCtD
Ketoconazole—Diarrhoea—Hydrocortisone—psoriasis	2.17e-05	0.000256	CcSEcCtD
Ketoconazole—Leukopenia—Methotrexate—psoriasis	2.16e-05	0.000256	CcSEcCtD
Ketoconazole—CYP3A4—Tryptophan metabolism—CAT—psoriasis	2.16e-05	0.000523	CbGpPWpGaD
Ketoconazole—Urticaria—Dexamethasone—psoriasis	2.15e-05	0.000254	CcSEcCtD
Ketoconazole—Urticaria—Betamethasone—psoriasis	2.15e-05	0.000254	CcSEcCtD
Ketoconazole—Musculoskeletal discomfort—Prednisone—psoriasis	2.15e-05	0.000254	CcSEcCtD
Ketoconazole—ABCB1—Allograft Rejection—IL10—psoriasis	2.14e-05	0.00052	CbGpPWpGaD
Ketoconazole—Dizziness—Prednisolone—psoriasis	2.14e-05	0.000254	CcSEcCtD
Ketoconazole—Asthenia—Triamcinolone—psoriasis	2.14e-05	0.000253	CcSEcCtD
Ketoconazole—Abdominal pain—Betamethasone—psoriasis	2.14e-05	0.000253	CcSEcCtD
Ketoconazole—Body temperature increased—Betamethasone—psoriasis	2.14e-05	0.000253	CcSEcCtD
Ketoconazole—Abdominal pain—Dexamethasone—psoriasis	2.14e-05	0.000253	CcSEcCtD
Ketoconazole—Body temperature increased—Dexamethasone—psoriasis	2.14e-05	0.000253	CcSEcCtD
Ketoconazole—Insomnia—Prednisone—psoriasis	2.13e-05	0.000252	CcSEcCtD
Ketoconazole—ABCB11—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.13e-05	0.000516	CbGpPWpGaD
Ketoconazole—Nausea—Cyclosporine—psoriasis	2.12e-05	0.000251	CcSEcCtD
Ketoconazole—Paraesthesia—Prednisone—psoriasis	2.12e-05	0.00025	CcSEcCtD
Ketoconazole—Pruritus—Triamcinolone—psoriasis	2.11e-05	0.00025	CcSEcCtD
Ketoconazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	2.1e-05	0.00051	CbGpPWpGaD
Ketoconazole—AR—Androgen receptor signaling pathway—STAT3—psoriasis	2.1e-05	0.00051	CbGpPWpGaD
Ketoconazole—Dizziness—Hydrocortisone—psoriasis	2.09e-05	0.000248	CcSEcCtD
Ketoconazole—ABCB1—Allograft Rejection—IL4—psoriasis	2.09e-05	0.000506	CbGpPWpGaD
Ketoconazole—Dyspepsia—Prednisone—psoriasis	2.07e-05	0.000245	CcSEcCtD
Ketoconazole—Nausea—Mycophenolate mofetil—psoriasis	2.06e-05	0.000244	CcSEcCtD
Ketoconazole—Arthralgia—Methotrexate—psoriasis	2.05e-05	0.000243	CcSEcCtD
Ketoconazole—Myalgia—Methotrexate—psoriasis	2.05e-05	0.000243	CcSEcCtD
Ketoconazole—Decreased appetite—Prednisone—psoriasis	2.05e-05	0.000242	CcSEcCtD
Ketoconazole—Rash—Prednisolone—psoriasis	2.04e-05	0.000242	CcSEcCtD
Ketoconazole—Dermatitis—Prednisolone—psoriasis	2.04e-05	0.000242	CcSEcCtD
Ketoconazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	2.04e-05	0.000241	CcSEcCtD
Ketoconazole—ABCB1—Allograft Rejection—HLA-B—psoriasis	2.04e-05	0.000495	CbGpPWpGaD
Ketoconazole—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	2.04e-05	0.000494	CbGpPWpGaD
Ketoconazole—Fatigue—Prednisone—psoriasis	2.03e-05	0.00024	CcSEcCtD
Ketoconazole—Headache—Prednisolone—psoriasis	2.03e-05	0.00024	CcSEcCtD
Ketoconazole—CYP27B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.03e-05	0.000492	CbGpPWpGaD
Ketoconazole—Discomfort—Methotrexate—psoriasis	2.03e-05	0.00024	CcSEcCtD
Ketoconazole—CYP21A2—Metabolism—CAT—psoriasis	2.03e-05	0.000491	CbGpPWpGaD
Ketoconazole—CYP1A1—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	2.03e-05	0.000491	CbGpPWpGaD
Ketoconazole—Constipation—Prednisone—psoriasis	2.01e-05	0.000238	CcSEcCtD
Ketoconazole—Vomiting—Hydrocortisone—psoriasis	2.01e-05	0.000238	CcSEcCtD
Ketoconazole—Rash—Hydrocortisone—psoriasis	2e-05	0.000236	CcSEcCtD
Ketoconazole—Dermatitis—Hydrocortisone—psoriasis	1.99e-05	0.000236	CcSEcCtD
Ketoconazole—AR—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	1.99e-05	0.000483	CbGpPWpGaD
Ketoconazole—Headache—Hydrocortisone—psoriasis	1.98e-05	0.000235	CcSEcCtD
Ketoconazole—Dizziness—Triamcinolone—psoriasis	1.97e-05	0.000233	CcSEcCtD
Ketoconazole—Anaphylactic shock—Methotrexate—psoriasis	1.97e-05	0.000233	CcSEcCtD
Ketoconazole—Feeling abnormal—Prednisone—psoriasis	1.94e-05	0.00023	CcSEcCtD
Ketoconazole—ABCB11—Metabolism—CYP2S1—psoriasis	1.94e-05	0.000471	CbGpPWpGaD
Ketoconazole—Asthenia—Betamethasone—psoriasis	1.94e-05	0.00023	CcSEcCtD
Ketoconazole—Asthenia—Dexamethasone—psoriasis	1.94e-05	0.00023	CcSEcCtD
Ketoconazole—Nervous system disorder—Methotrexate—psoriasis	1.93e-05	0.000229	CcSEcCtD
Ketoconazole—Thrombocytopenia—Methotrexate—psoriasis	1.93e-05	0.000228	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Prednisone—psoriasis	1.93e-05	0.000228	CcSEcCtD
Ketoconazole—Nausea—Prednisolone—psoriasis	1.93e-05	0.000228	CcSEcCtD
Ketoconazole—Pruritus—Dexamethasone—psoriasis	1.91e-05	0.000227	CcSEcCtD
Ketoconazole—Pruritus—Betamethasone—psoriasis	1.91e-05	0.000227	CcSEcCtD
Ketoconazole—Skin disorder—Methotrexate—psoriasis	1.91e-05	0.000226	CcSEcCtD
Ketoconazole—SLCO1A2—Metabolism—NDUFA5—psoriasis	1.91e-05	0.000462	CbGpPWpGaD
Ketoconazole—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	1.9e-05	0.00046	CbGpPWpGaD
Ketoconazole—Vomiting—Triamcinolone—psoriasis	1.9e-05	0.000224	CcSEcCtD
Ketoconazole—CYP27B1—Metabolism—CARM1—psoriasis	1.89e-05	0.000459	CbGpPWpGaD
Ketoconazole—ABCB1—Allograft Rejection—HLA-A—psoriasis	1.89e-05	0.000458	CbGpPWpGaD
Ketoconazole—Nausea—Hydrocortisone—psoriasis	1.88e-05	0.000223	CcSEcCtD
Ketoconazole—Rash—Triamcinolone—psoriasis	1.88e-05	0.000223	CcSEcCtD
Ketoconazole—Dermatitis—Triamcinolone—psoriasis	1.88e-05	0.000222	CcSEcCtD
Ketoconazole—Anorexia—Methotrexate—psoriasis	1.88e-05	0.000222	CcSEcCtD
Ketoconazole—Urticaria—Prednisone—psoriasis	1.87e-05	0.000222	CcSEcCtD
Ketoconazole—Headache—Triamcinolone—psoriasis	1.87e-05	0.000221	CcSEcCtD
Ketoconazole—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	1.87e-05	0.000453	CbGpPWpGaD
Ketoconazole—Body temperature increased—Prednisone—psoriasis	1.86e-05	0.00022	CcSEcCtD
Ketoconazole—Abdominal pain—Prednisone—psoriasis	1.86e-05	0.00022	CcSEcCtD
Ketoconazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	1.86e-05	0.000451	CbGpPWpGaD
Ketoconazole—Diarrhoea—Dexamethasone—psoriasis	1.85e-05	0.000219	CcSEcCtD
Ketoconazole—Diarrhoea—Betamethasone—psoriasis	1.85e-05	0.000219	CcSEcCtD
Ketoconazole—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.84e-05	0.000446	CbGpPWpGaD
Ketoconazole—Musculoskeletal discomfort—Methotrexate—psoriasis	1.79e-05	0.000212	CcSEcCtD
Ketoconazole—Dizziness—Dexamethasone—psoriasis	1.79e-05	0.000212	CcSEcCtD
Ketoconazole—Dizziness—Betamethasone—psoriasis	1.79e-05	0.000212	CcSEcCtD
Ketoconazole—Insomnia—Methotrexate—psoriasis	1.78e-05	0.000211	CcSEcCtD
Ketoconazole—SLCO1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.78e-05	0.000431	CbGpPWpGaD
Ketoconazole—SLCO1A2—Transmembrane transport of small molecules—CP—psoriasis	1.77e-05	0.000429	CbGpPWpGaD
Ketoconazole—Nausea—Triamcinolone—psoriasis	1.77e-05	0.00021	CcSEcCtD
Ketoconazole—CYP27B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.77e-05	0.000429	CbGpPWpGaD
Ketoconazole—Paraesthesia—Methotrexate—psoriasis	1.77e-05	0.000209	CcSEcCtD
Ketoconazole—Somnolence—Methotrexate—psoriasis	1.75e-05	0.000207	CcSEcCtD
Ketoconazole—Hypersensitivity—Prednisone—psoriasis	1.74e-05	0.000205	CcSEcCtD
Ketoconazole—Dyspepsia—Methotrexate—psoriasis	1.73e-05	0.000205	CcSEcCtD
Ketoconazole—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	1.73e-05	0.000419	CbGpPWpGaD
Ketoconazole—CYP24A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.73e-05	0.000419	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—NDUFA5—psoriasis	1.72e-05	0.000418	CbGpPWpGaD
Ketoconazole—Vomiting—Dexamethasone—psoriasis	1.72e-05	0.000204	CcSEcCtD
Ketoconazole—Vomiting—Betamethasone—psoriasis	1.72e-05	0.000204	CcSEcCtD
Ketoconazole—Decreased appetite—Methotrexate—psoriasis	1.71e-05	0.000203	CcSEcCtD
Ketoconazole—Rash—Betamethasone—psoriasis	1.71e-05	0.000202	CcSEcCtD
Ketoconazole—Rash—Dexamethasone—psoriasis	1.71e-05	0.000202	CcSEcCtD
Ketoconazole—Dermatitis—Betamethasone—psoriasis	1.7e-05	0.000202	CcSEcCtD
Ketoconazole—Dermatitis—Dexamethasone—psoriasis	1.7e-05	0.000202	CcSEcCtD
Ketoconazole—Gastrointestinal disorder—Methotrexate—psoriasis	1.7e-05	0.000201	CcSEcCtD
Ketoconazole—Fatigue—Methotrexate—psoriasis	1.7e-05	0.000201	CcSEcCtD
Ketoconazole—Headache—Dexamethasone—psoriasis	1.69e-05	0.000201	CcSEcCtD
Ketoconazole—Headache—Betamethasone—psoriasis	1.69e-05	0.000201	CcSEcCtD
Ketoconazole—Asthenia—Prednisone—psoriasis	1.69e-05	0.0002	CcSEcCtD
Ketoconazole—SLCO1A2—Transmembrane transport of small molecules—CARM1—psoriasis	1.69e-05	0.00041	CbGpPWpGaD
Ketoconazole—Pain—Methotrexate—psoriasis	1.68e-05	0.000199	CcSEcCtD
Ketoconazole—AR—SIDS Susceptibility Pathways—CXCL8—psoriasis	1.67e-05	0.000405	CbGpPWpGaD
Ketoconazole—Pruritus—Prednisone—psoriasis	1.67e-05	0.000197	CcSEcCtD
Ketoconazole—CYP1B1—Metabolism—NDUFA5—psoriasis	1.66e-05	0.000402	CbGpPWpGaD
Ketoconazole—Feeling abnormal—Methotrexate—psoriasis	1.62e-05	0.000192	CcSEcCtD
Ketoconazole—SLCO1A2—Metabolism—CYP2S1—psoriasis	1.62e-05	0.000393	CbGpPWpGaD
Ketoconazole—Diarrhoea—Prednisone—psoriasis	1.61e-05	0.000191	CcSEcCtD
Ketoconazole—Gastrointestinal pain—Methotrexate—psoriasis	1.61e-05	0.000191	CcSEcCtD
Ketoconazole—CYP24A1—Metabolism—CARM1—psoriasis	1.61e-05	0.00039	CbGpPWpGaD
Ketoconazole—Nausea—Betamethasone—psoriasis	1.61e-05	0.00019	CcSEcCtD
Ketoconazole—Nausea—Dexamethasone—psoriasis	1.61e-05	0.00019	CcSEcCtD
Ketoconazole—CYP19A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.61e-05	0.000389	CbGpPWpGaD
Ketoconazole—AR—Integrated Breast Cancer Pathway—JUN—psoriasis	1.59e-05	0.000386	CbGpPWpGaD
Ketoconazole—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.58e-05	0.000382	CbGpPWpGaD
Ketoconazole—CYP1A1—Aryl Hydrocarbon Receptor—TNF—psoriasis	1.58e-05	0.000382	CbGpPWpGaD
Ketoconazole—CYP21A2—Metabolism—APOE—psoriasis	1.57e-05	0.000382	CbGpPWpGaD
Ketoconazole—CYP11B2—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.57e-05	0.000381	CbGpPWpGaD
Ketoconazole—Urticaria—Methotrexate—psoriasis	1.56e-05	0.000185	CcSEcCtD
Ketoconazole—Dizziness—Prednisone—psoriasis	1.56e-05	0.000184	CcSEcCtD
Ketoconazole—Body temperature increased—Methotrexate—psoriasis	1.56e-05	0.000184	CcSEcCtD
Ketoconazole—Abdominal pain—Methotrexate—psoriasis	1.56e-05	0.000184	CcSEcCtD
Ketoconazole—AR—SIDS Susceptibility Pathways—JUN—psoriasis	1.55e-05	0.000376	CbGpPWpGaD
Ketoconazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	1.55e-05	0.000376	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.55e-05	0.000375	CbGpPWpGaD
Ketoconazole—AR—Integrated Breast Cancer Pathway—NFKB1—psoriasis	1.53e-05	0.000372	CbGpPWpGaD
Ketoconazole—CYP24A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.5e-05	0.000365	CbGpPWpGaD
Ketoconazole—Vomiting—Prednisone—psoriasis	1.5e-05	0.000177	CcSEcCtD
Ketoconazole—CYP3A7—Metabolism—NDUFA5—psoriasis	1.5e-05	0.000363	CbGpPWpGaD
Ketoconazole—AR—SIDS Susceptibility Pathways—NFKB1—psoriasis	1.49e-05	0.000362	CbGpPWpGaD
Ketoconazole—CYP51A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.49e-05	0.000361	CbGpPWpGaD
Ketoconazole—Rash—Prednisone—psoriasis	1.49e-05	0.000176	CcSEcCtD
Ketoconazole—Dermatitis—Prednisone—psoriasis	1.48e-05	0.000176	CcSEcCtD
Ketoconazole—CYP1A1—PPARA activates gene expression—PPARG—psoriasis	1.48e-05	0.000358	CbGpPWpGaD
Ketoconazole—Headache—Prednisone—psoriasis	1.48e-05	0.000175	CcSEcCtD
Ketoconazole—CYP19A1—Metabolism—CYP2S1—psoriasis	1.46e-05	0.000355	CbGpPWpGaD
Ketoconazole—CYP11B2—Metabolism—CARM1—psoriasis	1.46e-05	0.000355	CbGpPWpGaD
Ketoconazole—Hypersensitivity—Methotrexate—psoriasis	1.45e-05	0.000172	CcSEcCtD
Ketoconazole—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—psoriasis	1.45e-05	0.00035	CbGpPWpGaD
Ketoconazole—Asthenia—Methotrexate—psoriasis	1.41e-05	0.000167	CcSEcCtD
Ketoconazole—CYP1B1—Metabolism—CYP2S1—psoriasis	1.41e-05	0.000342	CbGpPWpGaD
Ketoconazole—CYP26A1—Metabolism—CAT—psoriasis	1.4e-05	0.00034	CbGpPWpGaD
Ketoconazole—Nausea—Prednisone—psoriasis	1.4e-05	0.000166	CcSEcCtD
Ketoconazole—Pruritus—Methotrexate—psoriasis	1.39e-05	0.000165	CcSEcCtD
Ketoconazole—AR—Integrated Breast Cancer Pathway—VEGFA—psoriasis	1.39e-05	0.000337	CbGpPWpGaD
Ketoconazole—CYP51A1—Metabolism—CARM1—psoriasis	1.39e-05	0.000337	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—NDUFA5—psoriasis	1.37e-05	0.000332	CbGpPWpGaD
Ketoconazole—CYP21A2—Metabolism—PPARG—psoriasis	1.37e-05	0.000332	CbGpPWpGaD
Ketoconazole—CYP19A1—Integrated Breast Cancer Pathway—JUN—psoriasis	1.37e-05	0.000332	CbGpPWpGaD
Ketoconazole—CYP11B2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.37e-05	0.000332	CbGpPWpGaD
Ketoconazole—AR—SIDS Susceptibility Pathways—VEGFA—psoriasis	1.36e-05	0.000329	CbGpPWpGaD
Ketoconazole—CYP11B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.35e-05	0.000328	CbGpPWpGaD
Ketoconazole—Diarrhoea—Methotrexate—psoriasis	1.35e-05	0.000159	CcSEcCtD
Ketoconazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	1.34e-05	0.000325	CbGpPWpGaD
Ketoconazole—AR—Generic Transcription Pathway—VDR—psoriasis	1.33e-05	0.000321	CbGpPWpGaD
Ketoconazole—AR—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.32e-05	0.00032	CbGpPWpGaD
Ketoconazole—CYP19A1—Integrated Breast Cancer Pathway—NFKB1—psoriasis	1.32e-05	0.00032	CbGpPWpGaD
Ketoconazole—Dizziness—Methotrexate—psoriasis	1.3e-05	0.000154	CcSEcCtD
Ketoconazole—CYP51A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.3e-05	0.000315	CbGpPWpGaD
Ketoconazole—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	1.29e-05	0.000313	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—CYP2S1—psoriasis	1.27e-05	0.000308	CbGpPWpGaD
Ketoconazole—AR—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.27e-05	0.000308	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.27e-05	0.000307	CbGpPWpGaD
Ketoconazole—CYP11B1—Metabolism—CARM1—psoriasis	1.26e-05	0.000306	CbGpPWpGaD
Ketoconazole—ABCB1—Allograft Rejection—IFNG—psoriasis	1.26e-05	0.000306	CbGpPWpGaD
Ketoconazole—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	1.26e-05	0.000305	CbGpPWpGaD
Ketoconazole—Vomiting—Methotrexate—psoriasis	1.25e-05	0.000148	CcSEcCtD
Ketoconazole—Rash—Methotrexate—psoriasis	1.24e-05	0.000147	CcSEcCtD
Ketoconazole—Dermatitis—Methotrexate—psoriasis	1.24e-05	0.000147	CcSEcCtD
Ketoconazole—Headache—Methotrexate—psoriasis	1.23e-05	0.000146	CcSEcCtD
Ketoconazole—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—psoriasis	1.2e-05	0.00029	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism—CARM1—psoriasis	1.18e-05	0.000286	CbGpPWpGaD
Ketoconazole—CYP11B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.18e-05	0.000286	CbGpPWpGaD
Ketoconazole—ABCB1—Allograft Rejection—CXCL8—psoriasis	1.17e-05	0.000284	CbGpPWpGaD
Ketoconazole—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	1.17e-05	0.000284	CbGpPWpGaD
Ketoconazole—Nausea—Methotrexate—psoriasis	1.17e-05	0.000138	CcSEcCtD
Ketoconazole—CYP2A6—Metabolism—CYP2S1—psoriasis	1.17e-05	0.000283	CbGpPWpGaD
Ketoconazole—CYP27B1—Metabolism—CAT—psoriasis	1.16e-05	0.000282	CbGpPWpGaD
Ketoconazole—AR—SIDS Susceptibility Pathways—TNF—psoriasis	1.16e-05	0.000282	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.16e-05	0.000281	CbGpPWpGaD
Ketoconazole—AR—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.15e-05	0.00028	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—NDUFA5—psoriasis	1.11e-05	0.000268	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.1e-05	0.000268	CbGpPWpGaD
Ketoconazole—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	1.1e-05	0.000267	CbGpPWpGaD
Ketoconazole—CYP26A1—Metabolism—APOE—psoriasis	1.09e-05	0.000265	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—NDUFA5—psoriasis	1.08e-05	0.000262	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism—CARM1—psoriasis	1.08e-05	0.000262	CbGpPWpGaD
Ketoconazole—AR—Gene Expression—CARM1—psoriasis	1.07e-05	0.000259	CbGpPWpGaD
Ketoconazole—AR—Integrated Breast Cancer Pathway—TP53—psoriasis	1.05e-05	0.000255	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—NDUFA5—psoriasis	1.02e-05	0.000248	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.02e-05	0.000247	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.01e-05	0.000245	CbGpPWpGaD
Ketoconazole—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1e-05	0.000244	CbGpPWpGaD
Ketoconazole—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	1e-05	0.000244	CbGpPWpGaD
Ketoconazole—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—psoriasis	9.96e-06	0.000241	CbGpPWpGaD
Ketoconazole—CYP24A1—Metabolism—CAT—psoriasis	9.89e-06	0.00024	CbGpPWpGaD
Ketoconazole—AR—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	9.88e-06	0.00024	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	9.66e-06	0.000234	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	9.53e-06	0.000231	CbGpPWpGaD
Ketoconazole—ABCB1—Allograft Rejection—VEGFA—psoriasis	9.52e-06	0.000231	CbGpPWpGaD
Ketoconazole—CYP26A1—Metabolism—PPARG—psoriasis	9.5e-06	0.00023	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism—CARM1—psoriasis	9.48e-06	0.00023	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—CYP2S1—psoriasis	9.41e-06	0.000228	CbGpPWpGaD
Ketoconazole—AR—SIDS Susceptibility Pathways—IL6—psoriasis	9.38e-06	0.000227	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—NDUFA5—psoriasis	9.37e-06	0.000227	CbGpPWpGaD
Ketoconazole—AR—Generic Transcription Pathway—PPARG—psoriasis	9.24e-06	0.000224	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—CYP2S1—psoriasis	9.19e-06	0.000223	CbGpPWpGaD
Ketoconazole—CYP19A1—Integrated Breast Cancer Pathway—TP53—psoriasis	9.05e-06	0.000219	CbGpPWpGaD
Ketoconazole—CYP27B1—Metabolism—APOE—psoriasis	9.04e-06	0.000219	CbGpPWpGaD
Ketoconazole—CYP11B2—Metabolism—CAT—psoriasis	9.01e-06	0.000218	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.86e-06	0.000215	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism of lipids and lipoproteins—CARM1—psoriasis	8.73e-06	0.000212	CbGpPWpGaD
Ketoconazole—AR—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	8.71e-06	0.000211	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—CYP2S1—psoriasis	8.69e-06	0.000211	CbGpPWpGaD
Ketoconazole—CYP51A1—Metabolism—CAT—psoriasis	8.54e-06	0.000207	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	8.49e-06	0.000206	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—NDUFA5—psoriasis	8.36e-06	0.000203	CbGpPWpGaD
Ketoconazole—ABCB1—Allograft Rejection—TNF—psoriasis	8.16e-06	0.000198	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—NDUFA5—psoriasis	8.16e-06	0.000198	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	8.11e-06	0.000197	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—CYP2S1—psoriasis	7.96e-06	0.000193	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism—CARM1—psoriasis	7.92e-06	0.000192	CbGpPWpGaD
Ketoconazole—CYP27B1—Metabolism—PPARG—psoriasis	7.88e-06	0.000191	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.8e-06	0.000189	CbGpPWpGaD
Ketoconazole—CYP11B1—Metabolism—CAT—psoriasis	7.76e-06	0.000188	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—NDUFA5—psoriasis	7.69e-06	0.000186	CbGpPWpGaD
Ketoconazole—CYP24A1—Metabolism—APOE—psoriasis	7.69e-06	0.000186	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.68e-06	0.000186	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—NDUFA5—psoriasis	7.62e-06	0.000185	CbGpPWpGaD
Ketoconazole—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	7.58e-06	0.000184	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	7.4e-06	0.000179	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism of lipids and lipoproteins—APOE—psoriasis	7.39e-06	0.000179	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism—CAT—psoriasis	7.26e-06	0.000176	CbGpPWpGaD
Ketoconazole—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	7.23e-06	0.000175	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—CARM1—psoriasis	7.15e-06	0.000173	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—CYP2S1—psoriasis	7.11e-06	0.000172	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	7.11e-06	0.000172	CbGpPWpGaD
Ketoconazole—CYP11B2—Metabolism—APOE—psoriasis	7e-06	0.00017	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—CYP2S1—psoriasis	6.94e-06	0.000168	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—CARM1—psoriasis	6.89e-06	0.000167	CbGpPWpGaD
Ketoconazole—CYP24A1—Metabolism—PPARG—psoriasis	6.7e-06	0.000162	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.69e-06	0.000162	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism—CAT—psoriasis	6.64e-06	0.000161	CbGpPWpGaD
Ketoconazole—CYP51A1—Metabolism—APOE—psoriasis	6.64e-06	0.000161	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—CYP2S1—psoriasis	6.54e-06	0.000159	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—NDUFA5—psoriasis	6.51e-06	0.000158	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—CYP2S1—psoriasis	6.48e-06	0.000157	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	6.44e-06	0.000156	CbGpPWpGaD
Ketoconazole—AR—Gene Expression—VDR—psoriasis	6.38e-06	0.000155	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—CARM1—psoriasis	6.21e-06	0.000151	CbGpPWpGaD
Ketoconazole—CYP11B2—Metabolism—PPARG—psoriasis	6.1e-06	0.000148	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.07e-06	0.000147	CbGpPWpGaD
Ketoconazole—CYP11B1—Metabolism—APOE—psoriasis	6.03e-06	0.000146	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism—CAT—psoriasis	5.83e-06	0.000141	CbGpPWpGaD
Ketoconazole—CYP51A1—Metabolism—PPARG—psoriasis	5.78e-06	0.00014	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—CARM1—psoriasis	5.69e-06	0.000138	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism—APOE—psoriasis	5.64e-06	0.000137	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—CYP2S1—psoriasis	5.54e-06	0.000134	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	5.38e-06	0.00013	CbGpPWpGaD
Ketoconazole—CYP11B1—Metabolism—PPARG—psoriasis	5.25e-06	0.000127	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	5.18e-06	0.000126	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism—APOE—psoriasis	5.16e-06	0.000125	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—NDUFA5—psoriasis	5.03e-06	0.000122	CbGpPWpGaD
Ketoconazole—CYP17A1—Metabolism—PPARG—psoriasis	4.92e-06	0.000119	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism—CAT—psoriasis	4.87e-06	0.000118	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	4.7e-06	0.000114	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—CARM1—psoriasis	4.59e-06	0.000111	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.55e-06	0.00011	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism—APOE—psoriasis	4.53e-06	0.00011	CbGpPWpGaD
Ketoconazole—CYP11A1—Metabolism—PPARG—psoriasis	4.5e-06	0.000109	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—CARM1—psoriasis	4.49e-06	0.000109	CbGpPWpGaD
Ketoconazole—AR—Gene Expression—PPARG—psoriasis	4.45e-06	0.000108	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—CAT—psoriasis	4.4e-06	0.000107	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—CYP2S1—psoriasis	4.27e-06	0.000104	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—CARM1—psoriasis	4.24e-06	0.000103	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—CAT—psoriasis	4.24e-06	0.000103	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism of lipids and lipoproteins—APOE—psoriasis	4.17e-06	0.000101	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	4.03e-06	9.77e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.97e-06	9.61e-05	CbGpPWpGaD
Ketoconazole—ABCB11—Metabolism—PPARG—psoriasis	3.95e-06	9.57e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—CARM1—psoriasis	3.89e-06	9.43e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—CAT—psoriasis	3.82e-06	9.26e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism—APOE—psoriasis	3.78e-06	9.17e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.73e-06	9.03e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.64e-06	8.81e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	3.55e-06	8.61e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—CAT—psoriasis	3.5e-06	8.49e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—CARM1—psoriasis	3.47e-06	8.42e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—APOE—psoriasis	3.42e-06	8.29e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.4e-06	8.24e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—CARM1—psoriasis	3.39e-06	8.22e-05	CbGpPWpGaD
Ketoconazole—SLCO1A2—Metabolism—PPARG—psoriasis	3.29e-06	7.99e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—APOE—psoriasis	3.29e-06	7.98e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	3.24e-06	7.87e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—CARM1—psoriasis	3.19e-06	7.74e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—CARM1—psoriasis	3.17e-06	7.67e-05	CbGpPWpGaD
Ketoconazole—CYP19A1—Metabolism—PPARG—psoriasis	2.98e-06	7.22e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—APOE—psoriasis	2.97e-06	7.2e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.96e-06	7.17e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.9e-06	7.04e-05	CbGpPWpGaD
Ketoconazole—CYP1B1—Metabolism—PPARG—psoriasis	2.87e-06	6.95e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—CAT—psoriasis	2.83e-06	6.85e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—CAT—psoriasis	2.76e-06	6.7e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—APOE—psoriasis	2.72e-06	6.6e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—CARM1—psoriasis	2.7e-06	6.56e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—CAT—psoriasis	2.61e-06	6.33e-05	CbGpPWpGaD
Ketoconazole—CYP3A7—Metabolism—PPARG—psoriasis	2.59e-06	6.27e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.53e-06	6.13e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—CAT—psoriasis	2.39e-06	5.8e-05	CbGpPWpGaD
Ketoconazole—CYP2A6—Metabolism—PPARG—psoriasis	2.37e-06	5.75e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—APOE—psoriasis	2.2e-06	5.32e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—APOE—psoriasis	2.15e-06	5.2e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—CAT—psoriasis	2.14e-06	5.18e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—CARM1—psoriasis	2.09e-06	5.06e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—CAT—psoriasis	2.08e-06	5.05e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—APOE—psoriasis	2.03e-06	4.92e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—CAT—psoriasis	1.96e-06	4.76e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—CAT—psoriasis	1.95e-06	4.72e-05	CbGpPWpGaD
Ketoconazole—CYP2B6—Metabolism—PPARG—psoriasis	1.91e-06	4.64e-05	CbGpPWpGaD
Ketoconazole—CYP3A5—Metabolism—PPARG—psoriasis	1.87e-06	4.53e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—APOE—psoriasis	1.86e-06	4.51e-05	CbGpPWpGaD
Ketoconazole—CYP1A1—Metabolism—PPARG—psoriasis	1.77e-06	4.28e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—CAT—psoriasis	1.66e-06	4.03e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—APOE—psoriasis	1.66e-06	4.02e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—APOE—psoriasis	1.62e-06	3.93e-05	CbGpPWpGaD
Ketoconazole—CYP2C8—Metabolism—PPARG—psoriasis	1.62e-06	3.93e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—APOE—psoriasis	1.53e-06	3.7e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—APOE—psoriasis	1.51e-06	3.67e-05	CbGpPWpGaD
Ketoconazole—CYP2C19—Metabolism—PPARG—psoriasis	1.45e-06	3.5e-05	CbGpPWpGaD
Ketoconazole—ABCB1—Metabolism—PPARG—psoriasis	1.41e-06	3.42e-05	CbGpPWpGaD
Ketoconazole—CYP2D6—Metabolism—PPARG—psoriasis	1.33e-06	3.22e-05	CbGpPWpGaD
Ketoconazole—CYP2C9—Metabolism—PPARG—psoriasis	1.32e-06	3.19e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—APOE—psoriasis	1.29e-06	3.13e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—CAT—psoriasis	1.28e-06	3.11e-05	CbGpPWpGaD
Ketoconazole—CYP1A2—Metabolism—PPARG—psoriasis	1.13e-06	2.73e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—APOE—psoriasis	9.98e-07	2.42e-05	CbGpPWpGaD
Ketoconazole—CYP3A4—Metabolism—PPARG—psoriasis	8.69e-07	2.11e-05	CbGpPWpGaD
